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Abstract
Background: Astrocytes respond to local insults within the brain and the spinal cord with important changes in
their phenotype. This process, overall known as “activation”, is observed upon proinflammatory stimulation and
leads astrocytes to acquire either a detrimental phenotype, thereby contributing to the neurodegenerative process,
or a protective phenotype, thus supporting neuronal survival. Within the mechanisms responsible for inflammatory
neurodegeneration, oxidative stress plays a major role and has recently been recognized to be heavily influenced
by changes in cytosolic iron levels. In this work, we investigated how activation affects the competence of
astrocytes to handle iron overload and the ensuing oxidative stress.
Methods: Cultures of pure cortical astrocytes were preincubated with proinflammatory cytokines (interleukin-1β
and tumor necrosis factor α) or conditioned medium from lipopolysaccharide-activated microglia to promote
activation and then exposed to a protocol of iron overload.
Results: We demonstrate that activated astrocytes display an efficient protection against iron-mediated oxidative
stress and cell death. Based on this evidence, we performed a comprehensive biochemical and molecular analysis,
including a transcriptomic approach, to identify the molecular basis of this resistance.
Conclusions: We propose the protective phenotype acquired after activation not to involve the most common
astrocytic antioxidant pathway, based on the Nrf2 transcription factor, but to result from a complex change in the
expression and activity of several genes involved in the control of cellular redox state.
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Background
Astrocytes represent the most abundant cell type in the
central nervous system (CNS), and they are key players for
both physiological neuronal functions and pathological
processes. They have long been recognized to provide en-
ergetic, metabolic and structural support to neurons
through the secretion of nutrients and the maintenance of
the blood–brain barrier integrity [1]. More recently, they
have been shown to exert a critical role in the extracellular
milieu homeostasis by controlling the concentration of
ions, mediators and neurotransmitters, thereby contribut-
ing to bidirectional neuron-glia communication [2].
Astrocytes are capable of undergoing rapid changes
in their phenotype as a result of alterations of CNS
homeostasis. This process, known as “astrocyte activa-
tion” or astrogliosis, is a well-established feature of sev-
eral pathological situations [3], in particular within
neuroinflammatory processes, in which an intense glial
fibrillary acidic protein staining can be observed [4,5].
The way astrocyte activation contributes to an either
neurodegenerative or neuroprotective role is still an
open question [6].
In this scenario, one important role that astrocytes
might play is related to oxidative stress, a condition
that has been ascribed to the reduction of antioxidant
defenses and/or to the increase in reactive oxygen spe-
cies (ROS) production [7]. Indeed, neurons are consid-
ered particularly vulnerable to oxidative stress because
of their high oxygen rate [8], and oxidative stress has
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been associated with neurodegeneration during aging,
as well as in several disorders, including Parkinson’s
and Alzheimer’s diseases [9]. Glial cell activation might
also occur in response to oxidative stress and involves a
complex range of responses that can either accelerate
or delay the neurotoxic effects [10]. Within this frame-
work, growing attention has been paid to the iron con-
tent, since it is known to favor free radical generation
by reacting with the H2O2 physiologically produced by
the cellular metabolism [11,12].
Several therapeutic strategies addressing oxidative
stress toxicity (e.g., the exogenous antioxidant supply)
and iron accumulation (e.g., metal chelation therapy)
have been attempted, and some proved to be effective
(see, for instance, [9,11,12]). While molecules with a dir-
ect protective effect on neurons have been searched for,
less attention has been paid to astrocytes, even though
they are an important alternative target, being a cellular
link between oxidative stress toxicity and neuroinflam-
mation [13], as well as key players in non-cell autono-
mous mechanisms of neurodegeneration [14]. Moreover,
astrocytic activity is reported to strongly condition iron
homeostasis in the CNS [15]. In fact, they control iron
flow through the blood–brain barrier and iron distribu-
tion to neurons. Since most of the extracellular iron in
the CNS is not bound to transferrin, astrocytes also play
an important role in buffering local iron changes,
thereby preventing oxidative stress in neurons (see [16]
and references therein).
In order to investigate the molecular basis and the ef-
fects of the astrocytic activation process under condi-
tions of oxidative stress, proper cellular models and
reliable in vitro assays are required. Many studies exploit
the use of continuous cell lines that, although easier to
handle, substantially differ from primary cultures in
terms of resistance to oxidative stress [17]. Primary glial
cultures are a better option, although proper care must
be taken in order to reproduce the process of activation
that occurs in vivo. In fact, the presence of a heteroge-
neous mixture of cell types in the culture may strongly
affect the outcome of the experiments, especially as
regards the contribution of microglia to inflammatory
conditions [18,19]. Secondary cultures of pure astrocytes
are often required to keep experimental variables under
control [18].
In this work, we set up a cellular assay in order to fol-
low iron-induced cell stress in highly standardized pure
secondary cultures of astrocytes obtained from rat cor-
tex. From this standpoint, we investigated the molecular
aspects that determine the resistance of astrocytes to
oxidative stress with particular regards to the effects of
proinflammatory activation. We also performed a tran-
scriptomic analysis in order to identify the candidate
genes involved in the mechanisms of protection.
Methods
Materials
Cell culture media and reagents were from BioWhittaker-
Lonza (Basel, Switzerland). Other chemicals, if not other-
wise stated, were from Sigma-Aldrich (St Louis, MO,
USA). Culture flasks and multiwell plates were from Nalge
Nunc (Rochester, NY, USA). Petri dishes were from Falcon
BD (Franklin Lakes, NJ, USA).
Cell culture
The animal use procedures were approved by the Insti-
tutional Animal Care and Use Committee of the San
Raffaele Scientific Institute. Primary cultures of cortical
astrocytes were prepared from 2- to 3-day-old Spra-
gue–Dawley rats (Charles River Italia, Calco, LC, Italy)
according to [19]. Briefly, after dissection, cortices were
cut into small sections with a razor blade. The pieces
were collected and washed twice in Hank’s Balanced
Salt Solution supplemented with 10 mM Hepes/Na pH
7.4, 12 mM MgSO4, 50 U/ml penicillin and 50 μg/ml
streptomycin (Gibco, Grand Island, NY, USA). The tis-
sue was then incubated, in two subsequent steps, with
2.5 mg/ml trypsin type IX in the presence of 1 mg/ml
deoxyribonuclease (Calbiochem, La Jolla, CA, USA)
for 10 min at 37°C and mechanically dissociated. The
supernatant obtained was diluted 1:1 in medium con-
taining 10% donor horse serum (PAA Laboratories
GmbH, Pasching, Austria). After centrifugation (100 g
for 10 min), cells were plated in Minimum Essential
Eagle Medium supplemented with 10% donor horse
serum, 33 mM glucose, 2 mM glutamax (Gibco), 50 U/ml
penicillin and 50 μg/ml streptomycin. Cells were main-
tained in 75 cm2 flasks (about 1 per pup) at 37°C in a
5% CO2 humidified incubator. In order to remove
microglia and oligodendrocyte progenitors and obtain
pure secondary cultures of astrocytes (>99.8%), flasks
were shaken at 200 rpm for 24 h at 37°C at days 2
and 6 after dissection in Minimum Essential Medium
with Hank's salts supplemented with 10% donor
horse serum, 33 mM glucose, 2 mM glutamax and 10
mM Hepes/Na, pH 7.4. Contamination with non-
astrocytic cells was assessed by immunocytochemistry
(GFAP for astrocytes, IBA1 for microglia and A2B5 for
oligodendrocyte precursors) according to [20]. After
reaching confluence, astrocytes were trypsinized and
replated in Minimum Essential Medium Eagle supple-
mented with 10% donor horse serum (BioWhittaker-
Lonza or, in comparative experiments, Invitrogen,
Carlsbad, CA, USA), 33 mM glucose, 2 mM glutamax,
50 U/ml penicillin and 50 μg/ml streptomycin onto
polylysine-coated glass coverslips or plastic multiwells.
Cultures were maintained at 37°C in a 5% CO2 humidi-
fied incubator, and experiments were performed within
3 days after re-plating.
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Dye loading
Dye loading was performed in Krebs-Ringer-Hepes buffer
(5 mM KCl, 125 mM NaCl, 2 mM CaCl2, 1.2 mM MgSO4,
1.2 mM KH2PO4, 6 mM glucose and 20 mM Hepes, pH
7.4). The fluorescent dyes (from Molecular Probes, Invitro-
gen, when not specified) were administered as follows: (1)
fura-2 acetoxymethyl ester (Calbiochem), 4 μM, 40 min at
37°C; (2) Sytox Blue, 5 μM, kept in the bath during the ex-
periments; (3) 5-(and-6)-chloromethyl-2’,7’-dichlorodihy-
drofluorescein diacetate, acetyl ester (CM-H2DCFDA),
0.25 μM, 30 min at 37°C; (4) tetramethyl rhodamine me-
thyl ester (TMRM), 25 nM, 15 min at room temperature
and maintained in the bath during the experiments. After
dye loading, cells were washed once with fresh Krebs-
Ringer-Hepes and analyzed in the same buffer. Both single
cell and monolayer culture experiments were performed at
room temperature.
Videomicroscopy setup
The videoimaging setup for single cell studies is based on
an Axioskope 2 microscope (Zeiss, Oberkochen, Germany)
and a Polychrome IV (Till Photonics GmbH, Martinsried,
Germany) light source. In the epifluorescence path,
fura-2 was excited at 355 nm to monitor Fe2+ variations
(as quenching of the fluorescence signal). The excita-
tion wavelength of 355 nm was adopted instead of
the theoretical 360-nm isosbestic wavelength because it
turned out to be insensitive to Ca2+ variations in our
optical configuration. Fluorescence images were collected
by a cooled CCD videocamera (PCO Computer Optics
GmbH, Kelheim, Germany). The Vision software (Till
Photonics) was used to control the acquisition protocol
and to perform data analysis.
Fluorescence plate reader measurements
The measurements of the fluorescence intensity for pure
astrocytic monolayers were based on a plate reader
(Mithras LB 940, Berthold Technologies or Wallac Vic-
tor3TM 1420 multilabel counter, Perkin Elmer) provided
with a flash lamp and sensitive PMTs coupled with high
transmission band pass filters. Briefly, treated or un-
treated astrocytes plated on 24-well plates were loaded
with fura-2 or CM-H2DCFDA, as previously described.
Fluorescence was measured every 60 s up to 90 min.
Cellular treatments
Fe2+ was prepared as a solution of ferrous-ammonium
sulfate, freshly dissolved in water and kept in ice until
use. Acute iron overload was performed by incubating
fura2-loaded astrocytes with 20 μM pyrithione, an iron iono-
phore, and Fe2+ 1 μM for 3 min to allow iron entry (moni-
tored by fura2 quenching). Cells were then washed twice
with Krebs-Ringer-Hepes solution to remove extracellular
Fe2+, and the fluorescence signal was monitored over time.
In some experiments, a pre-treatment with drugs or
pharmacologic agents was needed: (1) L-buthionine-
sulfoximine (BSO), an inhibitor of glutathione (GSH)
synthesis, 1 mM was added to the cellular medium 24 h
before the experiment; (2) Mito-TEMPO [(2-(2,2,6,6-
tetramethylpiperidin-1-oxyl-4-ylamino)-2-oxoethyl) tri-
phenylphosphonium chloride monohydrate; ENZO Life
Science, Farmingdale, NY, USA] 200 μM, as well as Trolox
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid)
1 mM were added to cells 2 h before the experiment; (3)




[N-acetyl-L-cysteine], 25 μM, was administered at the be-
ginning of the experiment (after acute iron overload) and
left until the end.
Astrocyte activation was induced by treating cells with
recombinant rat interleukin-1β (IL-1β) and tumor ne-
crosis factor α (TNFα) from R&D Systems (Minneapolis,
MN, USA). Stimuli were administered directly to the
culture medium 24 h before the experiment as follows:
10 ng/ml IL-1β and 30 ng/ml TNFα. Lipopolysaccharide
(LPS) (10 ng/ml) was added directly to the astrocyte cul-
ture medium 24 h before the experiment and used as a
negative control for activation. Conditioned medium ob-
tained from resting or activated (with 10 ng/ml LPS)
microglia was incubated on astrocytes in substitution for
their culture medium 24 h before the experiment.
GSH measurement
Reduced glutathione in pure astrocytic cultures was
measured by using QuantiChromTM Glutathione Assay
Kit (DIGIT-250) from BioAssay Systems (Hayward, CA,
USA). Treated or untreated astrocytes were washed and
then lysed for 15 min at 4°C with lysis buffer (150 μl for
two 35 × 10 petri dishes) containing phosphate-buffered
saline (137 mM NaCl, 2.7 mM KCl, 10 mM sodium
phosphate dibasic, 2 mM potassium phosphate mono-
basic, pH 7.4) supplemented with 2% Nonidet P-40, 10
mM EDTA/Na and a cocktail of protease inhibitors
(chymostatin, leupeptin, antipain and pepstatin dissolved
1000x in dimethylsulfoxide and used 10 μg/ml each).
Lysates were centrifuged for 15 min at 15,000 g at 4°C,
and 120 μl of the supernatant was mixed with 120 μl of
provided Reagent A (for deproteination and detection).
After vortexing, the sample/reagent A mixture was cen-
trifuged for 5 min at 15,000 g. Eventually, 200 μl of the
supernatant was added with 100 μl of provided reagent
B, i.e., 5,5’-dithiobis-2-nitrobenzoic acid, for colorimetric
reaction and transferred into the wells of a 96-well plate.
After an incubation of 25 min at room temperature,
absorbance of the samples was read at 412 nm. To con-
firm the obtained data, we also employed a Glutathione
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Fluorometric Assay Kit from Biovision (Milpitas, CA,
USA) according to the manufacturer’s instructions.
Cell viability assay
Cell viability was quantified by 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Briefly,
after treatment, pure cultures of astrocytes plated on 24-
well plates were incubated for 1 h at 37°C with 0.5 mg/ml
MTT in culture medium. After removing the extracellular
solution, formazan, the MTT metabolic product, was dis-
solved in dimethylsulfoxide, and the absorbance was read
at 570 nm.
DNA and siRNA transfection
DNA and siRNA transfections were performed using
Lipofectamine 2000 reagent (Life Technologies). Briefly,
DNA or siRNA (1.8 μg/ml and 200 pmol/ml, respect-
ively), as well as lipofectamine 2000 (4 μl/ml), was separ-
ately incubated with Optimem Reduced Serum Media
(Gibco) for 5 min at room temperature. Subsequently,
the Lipofectamine mix was added to DNA or siRNA mix
and left for 30 min at room temperature. Astrocytes
plated on 35 × 10-mm petri dishes or 24 multiwell plates
were washed once with Optimem and incubated with
the transfection solution for 90 min at 37°C. After two
washes with Optimem, astrocyte-conditioned medium
was eventually put on the cells. Twenty-four hours of
expression was required before performing the experi-
ments. SiRNAs used (forward and reverse) were: (1)
cgaccuacgugaacaaucutt and agauuguucacguaggucgcg for
the gene encoding mitochondrial superoxide dismutase
(SOD2); (2) agcuaguguagaaauaauatt and uauuauuucuaca
cuagcutt plus cgaguuacagugucuuaautt and auuaagacacu
guaacucggg for the nuclear factor (erythroid-derived 2)-
like 2 gene (NFE2L2) encoding Nrf2.
Western blotting
Cells were washed twice with phosphate-buffered sa-
line and lysed for 15 min at 4°C with 100 μl/petri dish
(35 × 10 mm) of lysis buffer (phosphate-buffered sa-
line supplemented with 2% Nonidet P-40, 0.2% sodium
dodecyl sulfate, 10 mM EDTA/Na and the cocktail of
protease inhibitors).
Lysates were centrifuged for 15 min at 15,000 g at 4°C,
and the supernatants were collected and their total protein
content analyzed by the MicroBCA reagent (ThermoFisher
Scientific, Pierce, Waltham, MA, USA). About 20–40 μg of
proteins was separated by standard sodium dodecyl sulfate
polyacrylamide gel electrophoresis and then electrically
transferred onto a nitrocellulose membrane in blotting buf-
fer [2.5 mM tris(hydroxymethyl)aminomethane, 19.2 mM
glycine, 20% methanol]. The nitrocellulose filter was stained
with Ponceau S (0.2% in 3% trichloroacetic acid) and de-
stained with double-distilled water for protein visualization.
Typically, membranes were blocked in washing solution
(10 mM tris(hydroxymethyl)aminomethane/HCl, 150 mM
NaCl, 0.1% Tween-20, pH 7.6) containing 5% non-fat dry
milk overnight at 4°C. Primary antibodies were diluted
in blocking solution and incubated for 2 h at room
temperature. Subsequently, membranes were washed three
times for 5 min with washing solution and incubated 1 h
with goat anti-rabbit or anti-mouse horseradish peroxidase-
conjugated secondary antibody (ThermoFisher Scientific,
Pierce) diluted in blocking solution at room temperature.
After three washing steps, protein bands were detected
on auto-radiographic films (GE Healthcare, Piscataway,
NJ, USA) by incubation with chemiluminescent solutions
(Pico or Super Signal West Femto chemiluminescent
kit, ThermoFisher Scientific, Pierce). The following primary
antibodies were used: (1) rabbit polyclonal anti-SOD2
antibody from Merck Millipore (Billerica, MA, USA); (2)
mouse monoclonal anti-catalase antibody from Sigma Al-
drich; (3) rabbit polyclonal anti-peroxiredoxin I, III and V
antibodies from AbFrontier (Korea); (4) goat polyclonal
anti-peroxiredoxin VI antibody from R&D Systems; (5)
rabbit polyclonal anti-SOD1 antibody from Santa Cruz Bio-
technology (Santa Cruz, CA, USA).
RNA extraction, reverse transcription and quantitative
PCR
RNA was extracted from treated or untreated cells plated
on 35 × 10-mm Petri dishes with TRIzol (Invitrogen) and
phenol/chlorophorm/isoamyl alcohol (25:24:1 v/v), follow-
ing the manufacturer’s instruction. Briefly, cells were
lysed in 1 ml of TRIzol, to which 200 μl of phenol/chloro-
phorm/isoamyl alcohol was added. After centrifugation
(12,000 g, 15 min.), the upper aqueous phase was trans-
ferred in a new tube, and RNA was precipitated through
addition of an equivalent amount of isopropanol. Samples
were centrifuged (12,000 g, 10 min) and washed with 70%
ethanol. RNA pellets were air-dried for 5 min, resus-
pended in 20 μl of RNase-free water and stored at −80°C.
Reverse transcription (RT) was carried out with random
hexamers as primers, using the Superscript III Retrotran-
scription Kit (Invitrogen) following the manufacturer’s
instructions. RT was performed at 50°C for 50 min, then
incubating samples were stopped at 85°C for 5 min.
Single-strand cDNA was obtained by digesting comple-
mentary RNA strands with provided RNase H for 20 min
at 37°C.
Quantitative polymerase chain reaction (qPCR) was per-
formed on a LightCycler 480 machine (Roche Diagnostics,
Basel, Switzerland), with proprietary SybrGreen mix
(LightCycler 480 Master Mix, Roche), following the manu-
facturer’s instructions. Both forward and reverse primers
were used at a 0.5 μM concentration. RT-derived cDNA
was typically diluted 1:4 before use. A PCR program was
performed with 10 min of the denaturation step at 95°C
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and 35 to 45 cycles of amplification. Each cycle consisted
of a denaturation step (95°C, 10 s), annealing step (60°C,
25 s) and elongation step (72°C, 15 s). After amplification,
a melting step was performed (95°C for 30 s, 60°C for 1
min). Determination of crossing points and melting peaks
was performed with LightCycler 480 Software (version
1.5.0.39, Roche). Primers used (forward and reverse) were:
(1) gacctacgtgaacaatctgaacg and cttgatagcctccagcaactct
for the gene encoding SOD2; (2) gcagagacattcccatttgta-
gat and cttaaatcagtcatggccgtct for the gene encoding
Nrf2; (3) tcaccattaagctgggcg and ttcttcccggtccagtcata for
the gene encoding frataxin; (4) gtatgaacagcgatgatgcact
and gaagaccagagcagattttcaatag for the gene encoding
interleukin-6 (used as a positive control for activation) and
(5) gaagaagaaattagagaagcgttcc and gtagtttacctgaccatccccat
for calmodulin 2 (used as an internal reference for
normalization).
Transcriptomic analysis
After the treatments, astrocytes were subjected to RNA ex-
traction using Trizol (Invitrogen), according to the manu-
facturer’s instructions. The gene expression profiling was
determined using RatRef-12 Expression Beadchips (Illu-
mina Inc., San Diego, CA, USA). Each beadchip investi-
gates for more than 21,000 transcripts selected primarily
from the NCBI RefSeq database (Release 16) and in a
minor part from the UniGene database. An amount of
500 ng of total RNA was reverse transcribed into comple-
mentary RNA and biotin-UTP labeled using the Illumina
TotalPrep RNA Amplification Kit (Applied Biosystems)
according to the manufacturer’s protocol; 750 ng of com-
plementary RNA was then hybridized to the BeadChip
array and stained with streptavidin-Cy3. All procedures
were performed following the manufacturer’s instructions.
BeadChips were imaged using the Illumina BeadArray
Reader, a two-channel 0.8-μm-resolution confocal laser
scanner and Illumina BeadScan software. Illumina Geno-
meStudio v.2011.1 software was used to elaborate the fluor-
escence signal to a value whose intensity corresponded to
the quantity of the respective transcript in the original sam-
ple. The same software was used to assess the quality con-
trols, which included the biological specimen controls,
hybridization controls, signal generation controls and nega-
tive controls. The samples belonging to three different ex-
perimental conditions (i.e., resting astrocytes, astrocytes
stimulated with cytokines and astrocytes stimulated with
microglia-conditioned medium) were tested in technical
duplicates, and a scatter plot with a correlation coefficient
for each couple of replicates was calculated, leading to a
mean value of 0.99. The fold change based on raw data was
calculated for the comparisons.
Data analysis was performed using the Ingenuity Path-
way Analysis (IPA) software (Ingenuity Systems Inc.,
Redwood City, CA, USA). lllumina probes, filtered for p
< 0.05 and a threshold of 1.5 points of fold change be-
tween different conditions (in upregulation or downreg-
ulation) were uploaded into the software together with
their differential expression p-values measured by t-test.
Each probe was mapped to its own gene object in the
Ingenuity Pathways Knowledge Database.
To interpret the gene expression results of the differ-
ent condition of stimulation in the context of biological
processes, pathways and networks, IPA Core Analyses
were conducted. Networks of these genes were assigned
a score based on their connectivity: the score reflected
the number of focus genes in the network and how rele-
vant this network is to the original list of focus genes.
The significance of the association between the data set
of genes and the canonical pathways contained in the In-
genuity Pathways Knowledge Database was determined
by adjusted p-values using the Benjamini-Hochberg cor-
rection for multiple testing, and a p-value < 0.05 after
correction was considered statistically significant accord-
ing to functional enrichment analysis. Besides, the “over-
lay” function was used to give a graphic visualization of
which subset of genes inside a given canonical pathway
was modulated in different conditions.
Data analysis
Data are presented as mean ± SEM of at least three in-
dependent experiments. Statistical significance was
tested by using either paired or unpaired two-tailed Stu-
dent’s t-test or one-way ANOVA followed by the Bonfer-
roni (for all pairwise comparisons) post hoc test.
Statistical analysis was performed using GraphPad Prism
(GraphPad Software, San Diego, CA, USA).
Results
Iron-dependent oxidative stress in cortical astrocytes
In order to evaluate the effects of oxidative stress on pure
cortical astrocytes in culture, we exposed cells to 1 μM
Fe2+ (administered as ferrous ammonium sulfate) for a
short time in the presence of 20 μM pyrithione, an iron
ionophore. Afterwards, cells were washed to stop iron
entry, and fluorescence was followed over time. This iron
overload protocol allows fast iron entry and a controlled
increase in its cytosolic concentration [21]. The intracellu-
lar levels of Fe2+ concentration were monitored by single-
cell videomicroscopy, by exploiting the capability of Fe2+
to quench fura-2 fluorescence (excitation at 360 nm, i.e.,
at the calcium insensitive wavelength). This dye was pre-
ferred to calcein, a widely used iron probe [22], since its
affinity, higher for Fe2+ (Kd 10-9) than for Fe3+ (Kd 10-6),
allows the discrimination between the two iron forms (see
also [17]). Quenching of intracellular fura-2 (i.e., the read-
out for Fe2+ entry) was first observed when the extracellu-
lar concentration of Fe2+ was raised above 0.3 μM—
thereby suggesting a basal level of free intracellular Fe2+
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around 0.5 μM—and was ~50% in the presence of 1 μM
(data not shown). The fluorescence quenching caused
by Fe2+ entry was maintained for a variable period of
time, after which a rapid and complete recovery of the
signal was observed (Figure 1A, gray thick trace). This
dequenching phase was most likely due to the oxidation of
Fe2+ to Fe3+ during the self-regenerative Fenton reaction.
In fact, it could also be triggered by administration of
H2O2 (data not shown; see also [17]). After a few seconds,
the dequenching was followed by a loss of plasma mem-
brane integrity, as indicated by both the drop of the fura-2
fluorescence signal (Figure 1A, gray thick trace) and the
concomitant nuclear staining by Sytox blue, a fluorescent
cell death indicator (Figure 1A, black thin trace).
Similar kinetics were observed when the iron overload
was investigated on a cell monolayer (analyzed by a
plate reader), even though fluorescence variations were
smoother, reflecting the integration of the asynchronous
signals coming from individual cells (Figure 1B, gray
thick trace). Accordingly, all following experiments were
performed on astrocyte monolayers if not otherwise
specified. In order to evaluate the effects of iron over-
load on the intracellular production of ROS, astrocyte
monolayers were also loaded with CM-H2DCFDA, a
reduced derivative of fluorescein, whose oxidation by
ROS induces an increase in fluorescence signal. ROS ac-
cumulation was observed to precede the rise of fura-2
fluorescence (Figure 1B, gray thin trace).
Since recent evidence suggested a protective role of
astrocyte activation against the oxidative stress induced by
H2O2 [23], we investigated whether this was the case also
in a condition of iron-mediated oxidative stress. Astro-
cytes were treated in vitro for 24 h with two proinflamma-
tory cytokines (CK: 10 ng/ml IL-1β + 30 ng/ml TNFα),
and the changes in their phenotype were assessed by
various activation markers, including interleukin-6, NO
and inducible NO synthase (data not shown, see also
[19]). When cytokine-activated astrocytes were exposed to
the iron overload protocol, after the initial quenching,
fura-2 fluorescence remained stable, with signs of neither
iron oxidation nor membrane alterations (Figure 1B, black
thick trace). Moreover, no ROS increase was observed
(Figure 1B, black thin trace). These results suggest that, in
astrocytes, ROS accumulation is responsible for cell death
after iron overload and activation confers resistance.
Effects of iron overload on mitochondria
Since mitochondria represent the main site of iron
utilization and ROS production, we investigated the effects
of iron overload on both their membrane potential and
morphology, looking at differences between resting and
activated astrocytes. Astrocytes were loaded with both
fura-2 and TMRM, a probe for mitochondrial membrane
potential, exposed to iron and analyzed at the single cell
level. In astrocytes at rest, TMRM fluorescence showed a
fast drop that just preceded the loss of fura-2 fluorescence,
i.e., the sign of cell death (Figure 2A), thereby suggesting
an impairment of mitochondrial functionality in the
oxidative stress-mediated cell death. When astrocytes
were activated by 24 h pretreatment with IL-1β and
TNFα, the mitochondrial membrane potential was pre-
served, and the cells were protected (Figure 2B). Of
note, iron overload also led to alteration of the mito-
chondrial morphology, converting the mitochondrial
shape (made visible by overexpression of a fluorescent
protein targeted to mitochondria) from elongated to
fragmented (Figure 2C, compare left panel with middle
panel). The activation process plays a protective role,
preserving mitochondrial morphology after iron chal-
lenge (Figure 2C, right panel).
Figure 1 Activation protects astrocytes from iron-dependent oxidative stress and cell death. (A) Acute 1 μM iron overload (from this
graph onwards indicated as Fe2+) was performed, and, after washing away extracellular Fe2+, the fluorescence of fura-2 (iron oxidative status) and
Sytox Blue (cell death) were monitored for up to 60 min. The temporal analysis traces show the behavior of a single representative astrocyte in a
microscopic field (expressed as relative fluorescence units, RFU). In this and in the following figures, the graphs are illustrative of at least three
independent experiments. (B) A monolayer of pure astrocytes was left untreated (C) or activated for 24 h with a mix of two proinflammatory
cytokines (CK: 10 ng/ml IL1β and 30 ng/ml TNFα). Cells were loaded with fura-2 (iron oxidative status) or CM-H2DCFDA (ROS detection) and then
challenged with the acute iron overload. The traces represent the fluorescence intensity (expressed as RFU) of the astrocytes plated in a well of a
24-well plate (about 250,000 cells).
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Effect of microglia activation on the astrocytic phenotype
Since the pretreatment with cytokines might not be
representative of the complex interplay between acti-
vated microglia and astrocytes, we employed a different
protocol of activation [23] that is expected to better
mimic the in vivo condition. Astrocytes were treated
for 24 h with conditioned medium obtained from quies-
cent (control) or LPS-treated microglia (MCM[−] and
MCM[+], respectively). Also in this experiment, astro-
cytes activated by pre-incubation with MCM[+] were
protected from the toxic effects of iron and did not show
the typical rise of fura-2 fluorescence (oxidative stress)
with ensuing cell death (Figure 3A). This result was not
influenced by the presence of LPS in the medium since
direct administration of LPS to our astrocyte cultures
(virtually devoid of contaminating microglia; see Methods
and [19]) induced neither activation nor protection from
oxidative stress (data not shown). The protecting pheno-
type obtained by incubation of astrocytes with either the
two pro-inflammatory cytokines or the MCM[+] was
further confirmed by an analysis of cell viability performed
with the colorimetric MTT assay (Figure 3B).
Role of glutathione and ROS scavengers
The oxidative stress, revealed by fura-2 dequenching
during the iron overload protocol, was clearly the conse-
quence of an imbalance between the ROS production
and cytosolic reducing potential of astrocytes. Since a re-
cent report showed that glutathione, the most important
antioxidant molecule in eukaryotic cells, is increased
upon astrocyte activation [24], we quantified the levels
of this antioxidant molecule in astrocytes under our ex-
perimental conditions. We found that GSH was higher
in activated than in resting astrocytes (Figure 4A), thus
indicating a higher competence of activated astrocytes to
maintain intracellular reducing conditions. A 24-h pre-
treatment with 1 mM BSO, an inhibitor of glutathione
synthesis, reduced the GSH content in both conditions
and abolished any difference. Moreover, the GSH levels,
after 30 min from iron overload, were significantly re-
duced in control conditions, but not in cytokine-treated
astrocytes (Figure 4B). In light of these results, we evalu-
ated the effects of glutathione depletion (24 h pre-
treatment with 1 mM BSO) on astrocytes exposed to the
iron overload protocol. In control astrocytes, both the
oxidative stress and the subsequent cell death were
significantly speeded up (compare the thick trace of
Figure 4C with the thick gray trace of Figure 1B), while
cytokine-activated astrocytes, after BSO treatment, showed
a variable level of protection, ranging from complete pre-
vention of cell death to a condition in which the damage
caused by oxidative stress was delayed, but not pre-
vented (Figure 4C, thin trace). The contribution of
glutathione in the protective mechanisms observed in
activated astrocytes was further confirmed by the effect
Figure 2 Activated astrocytes are protected from mitochondrial
damage induced by acute iron overload. (A, B) Cells were loaded
with both fura-2 and TMRM in order to monitor the iron oxidative
status (Fe2+) and mitochondrial membrane potential (ΔΨm),
respectively. After iron overload, the resting astrocyte (A) showed a
progressive ΔΨm decay before cell death (i.e., the drop of fura-2
signal). The signal of both fura-2 and TMRM, on the contrary,
remained stable in activated astrocytes (CK) challenged with iron
overload (B). The traces represent the temporal analysis of the
fluorescence within a single representative astrocyte in a
microscopic field (expressed as RFU). (C) In order to evaluate
mitochondrial morphology, cells were transfected with a
mitochondrial red fluorescent protein (left panel). Iron overload had
a strong effect on the mitochondrial morphology in resting
astrocytes (middle panel). In contrast, mitochondrial shape was
preserved in activated astrocytes (right panel).
Figure 3 Conditioned medium from LPS-activated microglia
protects astrocytes from iron-mediated toxicity. (A) A monolayer
of astrocytes was grown for 24 h with conditioned medium from
either quiescent microglia (MCM[−]) or 10 ng/ml LPS-activated
microglia (MCM[+]). Following acute iron overload, astrocytes,
treated with MCM[−], underwent iron oxidation and membrane
damage detected by fura-2 variations. MCM[+]-treated astrocytes
showed resistance. The traces represent the fluorescence intensity
analyzed with a plate reader and expressed as RFU. (B) Pure cultures
of astrocytes were left untreated (C) or treated for 24 h with either
cytokines (CK) or MCM[+], and analyzed 90 min after acute iron
overload. Cell viability was measured by MTT assay. Statistical
significance (***p < 0.001) was calculated using one-way ANOVA
followed by Bonferroni post hoc test.
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of 2AAPA, an irreversible inhibitor of glutathione re-
ductase. As expected, the decreased regeneration of
GSH by treatment with 2AAPA made astrocytes sus-
ceptible to oxidative stress even in their activated state
(Figure 4D). This confirms the contribution of glutathi-
one in the protective mechanism of activated astro-
cytes. We also compared the protection competence
acquired upon activation with the effects of exogen-
ously administered ROS scavengers. Among the various
molecules tested, we obtained significant results with
Mito-TEMPO and Trolox. The first is a mitochondrial
superoxide scavenger, previously shown to prevent
iron-induced mitochondrial alterations in neurons [17],
while the second is a water-soluble derivative of vita-
min E that protects against lipid peroxidation. An ana-
lysis with the MTT assay shows that both scavengers
reduce the astrocytic death caused by iron overload,
but are less effective than pretreatment with IL-1β and
TNFα (Figure 4E). As a note, sera from different compan-
ies and lots gave various degrees of astrocyte protection
against oxidative stress. Figure 4F shows the protective
effect exerted on resting astrocytes by a serum from
Invitrogen compared with the one used throughout this
study. A similar protective effect was also observed by
using a neuronal culture medium supplemented by B27, a
mix of neuroprotective and neurotrophic molecules that
includes antioxidants (data not shown).
Mechanisms involved in the protective phenotype of
activated astrocytes
In order to further investigate the mechanisms respon-
sible for the protective phenotype of activated astrocytes,
we evaluated the effects of the treatment with cytokines
on the expression of proteins involved in cellular de-
fenses against oxidative stress. We found no changes
in the expression of the following proteins: catalase,
SOD1, and peroxiredoxin 1, 3, 5 and 6, by Western blot
analysis; in frataxin mRNA levels, by RT-qPCR; in ferritin
H/L chain amount, by enzyme-linked immunosorbent
assay (data not shown). On the contrary, the expression of
the SOD2 protein, responsible for superoxide detoxifica-
tion at the mitochondrial level, was strongly induced in
activated astrocytes, and this upregulation was almost
completely prevented by transfection with specific siRNAs
Figure 4 Role of glutathione and antioxidant molecules against acute iron toxicity in astrocytes. (A) Reduced glutathione (GSH) was
measured in lysate of resting (C) or cytokine-activated (CK) astrocytes (average + SEM of three independent experiments). Statistical significance
(*p < 0.05) was calculated using unpaired two-tailed Student’s t-test. BSO was used as a control. (B) GSH was measured in resting (C) or activated
astrocytes (CK) in basal condition or after 30 min from iron overload. Columns represent the percent of GSH with respect to the control value of
resting astrocytes (average +SEM of eight independent experiments). Statistical significance (*p < 0.05; **p < 0.01) was calculated using one-way
ANOVA followed by Bonferroni. (C) A monolayer of resting (BSO) or cytokine-activated (BSO/CK) astrocytes was GSH depleted by BSO, loaded
with fura-2 and then challenged by iron. (D) After 90 min from iron overload, cell viability was measured (MTT assay) on astrocytes either in
resting condition (C), activated for 24 h with cytokines without (CK) or with (CK/2AAPA) 2AAPA. Each condition was expressed as the percent of
viability with respect to the corresponding control without Fe2+ challenge. Statistical analysis in this and the following panel was performed
using one-way ANOVA followed by Bonferroni (***p < 0.001). (E) After 90 min from acute iron overload, cell viability was measured (MTT assay)
on astrocytes in resting condition (C), activated for 24 h with cytokines (CK), or pretreated for 2 h with Mito-TEMPO (MT) or Trolox (*p < 0.05;
***p < 0.001). (F) Astrocytes were plated in culture media containing horse serum from two different companies (BioWhittaker or Invitrogen).
Cells were grown for 24 h, then loaded with fura-2 and challenged with iron overload. The traces represent the fluorescence intensity
(expressed as RFU) of the astrocytes analyzed by a plate reader.
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(Figure 5A and B). Therefore, we evaluated whether the
increased levels of SOD2 are responsible for the protective
phenotype observed in activated astrocytes. When SOD2
induction was silenced by siRNA transfection, we did not
observe a significant weakening of the protective effect
produced by the two proinflammatory cytokine treatments
against iron overload toxicity in either the fura-2-based
assay (Figure 5C) or the MTTassay (Figure 5D).
In parallel experiments we evaluated the protective re-
sponse of treatments able to increase GSH via induc-
tions of genes that are under control of the transcription
factor Nrf2 [25]. As expected, chronic treatments with
tert-butylhydroquinone and dopamine also produced a
protective response in astrocytes (see Additional file 1:
Figure S1). Since expression and activation of Nrf2 in
astrocytes can modulate the expression of detoxifying
enzymes involved in the oxidative stress response [26],
we first measured Nrf2 levels by RT-qPCR in resting and
activated astrocytes. Nrf2 expression increased upon
pre-treatment with IL-1β and TNFα (Figure 6A), and
this effect was reverted by transfection with specific siR-
NAs (data not shown). Interestingly, Nrf2 silencing re-
duced the protective effect of the proinflammatory
cytokines, as shown by MTT vitality assay (Figure 6B),
suggesting a possible role for this transcription factor in
astrocyte resistance to oxidative stress.
In order to further evaluate the contribution of Nrf2
in the astrocytic defense against oxidative stress and to
identify the molecular mechanisms accounting for the
activation-mediated protective phenotype, we performed
a wide gene expression profiling analysis in resting and
activated astrocytes (not exposed to iron overload) using
the Illumina RatRef chip technology. Total RNA from
resting or activated astrocytes was analyzed for the ex-
pression of the ~22,000 genes available on the chip. By
comparing cytokine-activated and resting astrocytes, we
identified 354 genes with a >two-fold increased expres-
sion, among which 170 genes had a >3-fold increased
expression; in addition, we found 253 genes with a >50%
reduced expression, among which 60 genes had a >66%
reduced expression. Since the phenotype obtained by ex-
posure to the two proinflammatory cytokines is similar to
that obtained by MCM[+] (Figure 3; see also [23]), we also
performed the gene expression profiling on astrocytes ex-
posed to MCM[+], obtaining similar results. In Additional
file 2: Table S1, we list the genes that we found to be up-
or downregulated, with a minimum of a two-fold change,
after exposure to IL-1β and TNFα (CK) or MCM[+].
Next, we performed a network analysis with the In-
genuity web software on the up- and downregulated
Figure 5 SOD2 is not involved in cytokine-mediated protection
of astrocytes. (A) The expression of SOD2 was analyzed in resting
(C) and cytokine-activated (CK) astrocytes by RT-qPCR. Statistical
analysis was calculated by using paired two-tailed Student’s t-test.
(*p < 0.05). (B) Resting astrocytes were incubated with lipofectamine
alone (controls, for this and the following experiments), or
transfected for 90 min with either a SOD2-specific siRNA or a
control siRNA (against the Dmt1 transcript). After at least 6 h from
transfection, astrocytes were treated with cytokines to induce
activation. Efficiency of silencing was assessed by Western blot
analysis. (C) Acute iron overload was performed on fura-2 loaded
monolayers of either resting (C) or activated (CK) astrocytes with or
without SOD2 silencing. Oxidative stress (recovery of fura-2 signal)
and cell death (dye loss) were monitored by a fluorescence plate
reader. (D) Ninety minutes after iron overload, cell viability (MTT
assay) was measured on resting astrocytes (C) or activated (CK)
astrocytes, with or without SOD2 silencing. Statistical analysis was
performed by using one-way ANOVA followed by Bonferroni post
hoc test. (**p < 0.01; ***p < 0.001).
Figure 6 Downregulation of Nrf2 impairs protection of
astrocytes against iron overload. (A) The expression of Nrf2 was
analyzed by RT-qPCR in resting (C) and cytokine-activated (CK)
astrocytes. Statistical analysis was calculated by using paired two-
tailed Student’s t-test. (*p < 0.05). (B) Resting astrocytes were
incubated with lipofectamine alone or transfected with a mix of two
Nrf2-specific siRNAs for 90 min. After at least 6 h from transfection,
astrocytes were treated with proinflammatory cytokines to induce
activation. Twenty-four hours later, an acute iron overload protocol
was performed, and after 90 min cell viability (MTT assay) was
measured on resting (C) or activated astrocytes (CK) subjected or
not to Nrf2 silencing. Statistical analysis was performed by using
one-way ANOVA followed by Bonferroni post hoc test. (*p < 0.05;
**p < 0.01; ***p < 0.001).
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molecules in activated astrocytes. The network related
to oxidative stress (Figure 7) was the second best
ranked (p < 10-37) and included Nrf2 (NFE2L2 in the
figure), whose mRNA expression, upregulated in acti-
vated astrocytes, was linked to an increased expression
of molecules involved in the inflammatory pathways,
such as IL-1β, a common hallmark of astrocyte activa-
tion. Many other molecules and pathways emerged as
part of this network, and the modulation of some of
them was in line with our experimental evidence (i.e.,
SOD2, glutathione peroxidase). This bioinformatic ana-
lysis was then extended to examine first the genes iden-
tified by Röhl and colleagues [23], then to the Nrf2
pathway and, eventually, to the whole field of oxidative
stress response genes.
In Table 1, the expression of the genes identified by
Röhl and colleagues [23] after astrocyte activation is rep-
resented as the percentage of variation with respect to
the value obtained in resting condition. Our data appear
to be consistent with those obtained by Röhl and col-
leagues [23], and no major differences emerged between
the CK (IL-1β + TNFα) and MCM[+] treatments, apart
from the fact that the changes in gene expression appear
to be more pronounced in our conditions of acute
stimulation (24 h) than after the longer incubation time
(7 days) employed by Röhl and colleagues [23].
Figure 7 Transcriptomic analysis of activated astrocytes reveals a modulation of genes involved in both inflammatory and the
antioxidant responses. RNA was extracted from resting astrocytes or astrocytes activated for 24 h with 10 ng/ml IL-1β and 30 ng/ml TNFα.
Gene expression variations were analyzed by the Ingenuity software and graphically represented (upregulated in red and downregulated in
green) as interconnections into a network.
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In light of the importance of the astrocytic Nrf2 path-
way in the protection of neurons from a wide array of
insults [27], we then analyzed the transcriptomic data
with the Ingenuity software to evaluate the level of
activation of the Nrf2 pathway in activated astrocytes.
Figure 8 illustrates the genes that are under the control
of Nrf2 and that underwent downregulation (green) or
upregulation (red), with respect to control expression
measured in resting astrocytes, after 24 h of activation
with either CK or MCM[+]. Although the transcriptomic
data confirm the moderate upregulation of Nrf2 ob-
served by RT-qPCR (see Figure 6A), the Nrf2 pathway
does not seem to be responsible for the protection of ac-
tivated astrocytes since the majority of the genes that are
transcriptionally activated by Nrf2 remained unchanged
or showed a slight tendency to decrease. Therefore, we
can assume that the additional Nrf2 expressed in acti-
vated astrocytes is bound to its repressor Keap1.
Finally, we extended our analysis to a list of genes that
are not limited to those regulated by the Nrf2 transcrip-
tion factor but are commonly present in the PCR array
kits designed for the study of the oxidative stress re-
sponse (see, e.g., the SABioscience PCR array kit). We
used a threshold that also highlights subtle changes in
expression. Figure 9 shows the heat maps of upregula-
tion (red) and downregulation (green) of these selected
genes: on the left, the variation of gene expression upon
CK treatment is displayed in descending order; on the
right, the same genes are shown after MCM[+] treat-
ment. In general, there were no major changes in the
mRNA expression of glutathione peroxidases and perox-
iredoxins, with the exception of PRXD5, which was
significantly upregulated with MCM[+] treatment (see
Additional file 2: Table S1). Of note, TXNRD1 (thiore-
doxin reductase, involved in the regeneration of peroxir-
edoxins) appeared slightly upregulated. Looking at the
other genes that are changed with both treatments, it is
possible to note the strong upregulation of the chemo-
kine CCL5, considered an internal control of astrocyte
activation, as well as SOD2 and nitric oxide synthase 2
(NOS2), as expected. Of potential interest were the up-
regulation of epoxide hydrolase 2 (EPHX2) and the
downregulation of aldehyde oxidase 1 (AOX1), two en-
zymes that might play an important role in radical spe-
cies detoxification and generation, respectively.
Discussion
In this work, we evaluate the capability of astrocytes to
cope with the oxidative stress induced by moderate and
acute intracellular Fe2+ accumulation promoted by an
iron ionophore. The reason behind this is that iron
dysregulation and accumulation are common features
of both ageing and neurodegenerative disorders and
that Fe2+ favors the production of the highly toxic hy-
droxyl radicals by reacting with the H2O2 (within the
framework of the self-regenerative Fenton reaction) that
is physiologically produced during cellular metabolism.
Under our experimental conditions, astrocytes appeared
to stand the iron overload for variable periods of time,
most likely up to exhaustion of their antioxidant poten-
tial. Afterward, an acute intracellular burst of oxidative
stress was observed, and this is expected to reflect the
reaction of Fe2+ with the intracellular H2O2, with con-
sequent lipid peroxidation, loss of membrane integrity
and, as a final event, cell death. The whole process oc-
curred within minutes and appeared to depend not
only on the cellular state, but also on the culture condi-
tions. In fact, the presence of antioxidants in the cul-
ture medium was able to delay the entire process,
including cell death.
Based on the work of Röhl and colleagues [23], in
which astrocytes pretreated with conditioned medium
Table 1 mRNA expression of selected genes under
activation conditions
Gene 2CK vs. C MCM[+] vs. C MCM[+] vs. C (Röhl et al., 2008)
Rbp1 2,300 1,697 490
Sod2 1,511 2,322 2,200
Ass 1,422 384 135
Txnrd1 173 133 145
Gss 141 126 93
Prdx5 137 241 120
Prdx6 136 105 63
Cat 132 86 63
Gstp1 123 111 220
Hsbp1 119 92 45
Sod1 110 93 96
Mt1a 106 475 67
Nme1 104 91 80
Gstm3 102 92 62
G6pdx 101 91 100
Nme2 94 104 90
Gsr 90 104 135
Gstm1 90 116 88
Gpx1 81 65 60
Gstm2 75 120 120
Gclc 53 42 73
RNA was extracted from resting astrocytes (C, control) or astrocytes activated
for 24 h with either proinflammatory cytokines (CK: 10 ng/ml IL-1β and 30 ng/
ml TNFα) or conditioned medium from LPS-activated microglia (MCM[+]). The
gene expression levels were determined through the Illumina BeadArray
technology using RatRef-12 Expression Beadchips. The values corresponding
to each gene expressed by activated astrocytes represent the percent with
respect to the values of resting astrocytes. Values of the changes in gene
expression relative to activated astrocytes in Röhl’s work were extrapolated
from the analysis shown in the corresponding paper [23].
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from LPS-activated microglia (MCM[+]) and were found
to be resistant to extracellular H2O2 administration, we
considered the possibility that activated astrocytes might
also be protected against the oxidative stress mediated
by intracellular iron loading. In fact, the recently re-
ported increase in iron import observed in activated as-
trocytes [28] could trigger oxidative stress if specific
protective mechanisms are not induced.
The conversion of astrocytes from the resting to reactive
state is well described in animal models of acute CNS in-
jury and neurodegeneration [29]. However, under in vivo
conditions, it is difficult to identify the causative mecha-
nisms of the astrogliosis process, since they result from
the complex integration of the responses of the various
cell types present in the CNS. We reproduced the process
of reactive astrogliosis by exposing astrocytes to IL-1β and
TNFα, the two main cytokines released from activated
microglia [30], as well as to MCM[+], a condition that is
expected to better mimic the in vivo situation since LPS
induces the release of a wide spectrum of proinflammatory
molecules from microglia [31]. From our data, it is clear
that TNFα and IL-1β are able to reproduce, in broad out-
line, the more complex scenario that was supposed to re-
sult from the mix of factors released by LPS-activated
microglia, and, in both models, activated astrocytes ac-
quired a protective competence not only towards H2O2,
but also iron overload, with prevention of both oxidative
stress and cell death. More intriguing was the analysis of
the determinants of this protective phenotype. We
employed a transcriptomic approach with the aim to in-
vestigate the changes in a wide panel of genes involved in
the oxidative stress response. First of all, the transcrip-
tomic analysis rules out a possible reinforcement of the
control of iron detoxification, since the analysis of the
transcripts did not show an increased expression of pro-
teins involved in iron extrusion and storage. The only
clear evidence from both the biochemical and transcrip-
tomic analysis was a great increase in SOD2 expression
upon activation. This draws attention to the mitochondrial
enzymes that, in astrocytes exposed to inflammatory cyto-
kines, are expected to have a pivotal role. Indeed, the dys-
function of these organelles is generally considered one of
the primary causes of cell death in neurodegenerative dis-
eases [32], a view that finds confirmation in the high sensi-
tivity of mitochondria to ROS injury. Many antioxidant
therapies have been proposed to protect mitochondria,
and thus to prevent neuronal damage; however, this thera-
peutic strategy has turned out to be too simplistic, given
Figure 8 The Nrf2 pathway is not activated after proinflammatory stimulation of astrocytes. The canonical pathway of the Nrf2
transcription factor was analyzed with Ingenuity software. Left panel shows downregulated (green) and upregulated (red) genes in cytokine-
activated astrocytes; right panel shows the same genes in MCM[+]-activated astrocytes.
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Figure 9 Heat map of up- and downregulated genes after activation with CK and MCM[+]. Upregulated (red) and downregulated (green)
genes are listed in descending order according to the CK stimulation (left column). The same genes are also analyzed for MCM[+] stimulation
(right column).
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the complexity of mitochondrial ROS metabolism. In fact,
the process of astrocyte activation is expected to increase
the mitochondrial resistance against oxidative stress by
acting on a multiplicity of targets, for instance, by control-
ling the synthesis of SOD2, mitochondrial peroxiredoxins
and glutathione. Within this complex framework, how-
ever, it is difficult to put all of them into perspective. If we
consider the role SOD2 expression can play in the pres-
ence of iron overload, we can infer that removal of super-
oxide from mitochondria limits the self-regeneration
(Haber-Weiss reaction) of the substrate for the Fenton re-
action, as this molecule is able to reduce Fe3+ to the react-
ive Fe2+. However, superoxide dismutation also causes an
elevation of H2O2, a condition that is extremely harmful
in the presence of Fe2+ since it leads to the production of
the hydroxyl radicals. Activated astrocytes appear to better
deal with this problem, since they contain higher levels of
not only SOD2, but also reduced glutathione with respect
to resting astrocytes. Therefore, activated astrocytes ap-
pear to neutralize the harmful potential of iron by detoxi-
fying mitochondria from superoxide as well as H2O2.
Within this general view, the involvement of SOD2 ap-
pears to be less critical than that of glutathione. In fact, si-
lencing of SOD2 did not revert the protective phenotype,
while changes in the level of glutathione significantly af-
fected the protective competence of astrocytes, suggesting
that H2O2 detoxification is more critical than the disposal
of excess superoxide.
Astrocytes are known to respond to oxidative stress with
changes in gene expression, and the transcription factor
Nrf2 was reported to play a central role in raising astro-
cytic antioxidant defenses [33]. In particular, a new mode
of action of natural antioxidant compounds has recently
emerged in which the induction of the Nrf2 pathway
promotes the transcription of downstream genes involved
in the protection against both oxidative stress—among
others, glutathione—and inflammation [34]. However,
when we exposed astrocytes to proinflammatory condi-
tions, the Nrf2 pathway did not appear to be activated. It
should be noted in this respect that the Nrf2 response
against oxidative stress is activated mainly by modulation
of the interaction of Nrf2 with Keap1, i.e., the repressor of
its translocation to the nucleus, and not by the simple
upregulation of the Nrf2 gene [35]. Overall, although acti-
vated astrocytes are reported to show a moderate upregu-
lation of Nrf2 expression, the expression of the Nrf2 target
genes was almost unaffected in our experimental condi-
tions, leading us to conclude that the Nrf2 pathway does
not contribute to the protective phenotype by increasing
glutathione levels. In any event, it is clear that even if the
glutathione level is important against oxidative stress, it
cannot fully account for the differences observed between
quiescent and activated astrocytes. In fact, even when de-
pleted of this antioxidant molecule, activated astrocytes
were more resistant to iron-mediated toxicity and cell
death, thereby suggesting that other molecules potenti-
ate the defense system. In addition to glutathione per-
oxidases and peroxiredoxins, recognized as key enzymes
for H2O2 detoxification in astrocytes [36,37], our tran-
scriptomic approach revealed new potential candidates
for oxidative stress control. Of particular interest are
TXNRD1, involved in the peroxiredoxin-mediated detoxi-
fication of H2O2 via regeneration of thioredoxins [38], and
EPHX2, a hydrolase that might help to detoxify reactive
epoxydes formed during oxidative stress [39]. Moreover, a
downregulation of enzymes that produce H2O2, such as
the aldehyde oxidase 1, which was identified in our ana-
lysis, might also contribute to decreasing the oxidative
load of astrocytes. Further work is required to better de-
fine the role of these genes, and, in particular, it must be
taken into account that the resistance of activated astro-
cytes might rely not only on changes in the expression of
specific mRNAs, but also on changes in the activity of
enzymes, an issue that could not be addressed by a simple
transcriptomic analysis.
Conclusions
In conclusion, the biochemical and transcriptomic analysis
of astrocytes exposed to cytokines (IL-1β and TNFα) or
MCM[+] suggests a complex protective mechanism that
does not involve the Nrf2 pathway and might see the con-
vergence and the synergy between several genes. The rela-
tive contribution of each of these genes has to be
considered in a wider context, with particular attention to
the molecules that might activate non-cell autonomous
mechanisms of neuronal protection.
Additional file
Additional file 1: Figure S1. Chronic treatment with tert-
butylhydroquinone or dopamine protects astrocytes from acute iron
overload. Cell viability (MTT assay) was measured after iron overload
(Fe2+) in resting astrocytes (C) and in astrocytes pretreated for 16 h with
either 50 μM tert-buthylhydroquinone (tBHQ) or 100 μM dopamine
(DA, in the presence or absence of 1 mM BSO).
Additional file 2: Table S1. List of genes that are up- or
downregulated at least two fold upon CK or MCM[+] treatment.
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